Reference
1. Momtazmanesh S, Moghadam SS, Gamari SHand others. 2023. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. eClinicalMedicine 59:101936
2. Global Asthma Network. 2022. Global Asthma Report. International Journal of Tuberculosis and Lung Disease 26(Supplement 1): 1–104.
3. Haughney J, Winders TA, Holmes Sand others. 2020. Global quality standards for diagnosis and management of severe asthma. advances in therapy 37(9): 3645-59
4.Jo EJ, Kim MY, Kim SHand others. 2020. Implementation of asthma management guidelines and potential barriers in Korea. Korean Medical Science Journal 35(12):e72
5. Nunes C, Pereira AM, Morais-Almeida M. 2017. The costs and social impact of asthma. Asthma Research and Practice 3:1
6. Song HJ, Blake KV, Wilson DLand others. 2020. Medical costs and lost productivity due to mild, moderate, and severe asthma in the United States. Asthma and Allergy Journal 13:545-55
7. Hecking PW, Weiner RR, Emelink Mand others. 2015. Prevalence of severe refractory asthma. Journal of Allergy and Clinical Immunology 135(4): 896-902
8. Roche N, Garcia G, Larrard ed.and others. 2022. Real-life impact of uncontrolled severe asthma on mortality and health care utilization in adolescents and adults: findings from the retrospective, observational Resonance Study in France. British Medical Journal Open 12(8): e060160
9. Chung KF, Wenzel SE, Brozek JLand others. 2014. International ERS/ATS guidelines on definition, assessment and treatment of severe asthma. European Respiratory Journal 43(2): 343-73
10. Asthma + Lung’s UK. 2020. Falling into isolation: The lived experiences of people with severe asthma. London: Asthma + Lungs UK
11. Global Initiative for Asthma (GINA). 2023. Global strategy for asthma management and prevention. Fontana, WI: GINA
12. Foster JM, McDonald VM, Guo Mand others. 2017. “I am defeated in every aspect of my life”: The hidden burden of severe asthma. European Respiratory Journal 50(3): 1700765
13. Wang E, Wexler ME, Tran TNand others. 2020. Characteristics of severe asthma worldwide. Chest 157(4): 790-804
[पबमेड]14. Scalo G, Towers-Duke CA, Maspero Jand others. 2024. Analysis of comorbidity and multimorbidity in adult patients in the International Severe Asthma Registry. History of allergy, asthma and immunology 132(1): 42-53
15. Shaw DE, Sousa AR, Fowler SJand others. 2015. Clinical and inflammatory characteristics of the European U-BioPred adult severe asthma cohort. European Respiratory Journal 46(5): 1308-21
16. Sadatsafavi M, Lind L, Marra C. 2010. Direct health care costs associated with asthma in British Columbia. Canadian Respiratory Journal 17(2): 74-80
17. Rupani H, Rose J, Cumella A.and others. 2022. p145 What is the severe asthma patient’s journey to biologic initiation in UK acute asthma centres? Breast 77(Suppl 1): A159–A60.
18. Asthma + Lung UK. 2019. Living in limbo: A scale of unmet need in severe and severe asthma. London: Asthma + Lungs UK
19. Menzies-Go A, Jackson DJ, Al-Ahmad Mand others. 2022. A renewed charter: key principles for improving patient care in severe asthma. advances in therapy 39(12): 5307-26
20. Price DB, Trudeau F, Voorham Jand others. 2018. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. Asthma and Allergy Journal 11: 193-204
21. Gonzalez de la Fuente A, Waite S. 2023. A breath of fresh air: addressing missed opportunities in acute asthma care. London: Health Policy Partnership
Z4-62664 Preparation date: May 2024